EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal

Corrado Minetti, Rachael Barton, Caitlin Farley, Owen Brad Spiller, Raquel Rodrigues, Paulo Gonçalves

European Journal of Clinical Microbiology & Infectious Diseases · 2024-07 · 43 (7) · 1297-1308

DOI: 10.1007/s10096-024-04789-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 02.05.2024. Verfasst von Corrado Minetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Anti-Bacterial Agents, Legionella pneumophila, Azithromycin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Saúde Dr. Ricardo Jorge.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgroud Although not fully investigated, studies show that Legionella pneumophila can develop antibiotic resistance. As there is limited data available for Portugal, we determined the antibiotic susceptibility profile of Portuguese L. pneumophila serogroup 1 (LpnSg1) isolates against antibiotics used in the clinical practice in Portugal.

Methods

Minimum inhibitory concentrations (MICs) were determined for LpnSg1 clinical ( n = 100) and related environmental ( n = 7) isolates, collected between 2006–2022 in the context of the National Legionnaire´s Disease Surveillance Programme, against azithromycin, clarithromycin, erythromycin, levofloxacin, ciprofloxacin, moxifloxacin, rifampicin, doxycycline, tigecycline, and amoxicillin/clavulanic acid, using three different assays. Isolates were also PCR-screened for the presence of the lpeAB gene.

Results

Twelve isolates had azithromycin MICs above the EUCAST tentative highest WT MIC, 9 of which were lpeAB negative; for erythromycin and clarithromycin, all isolates tested within the susceptible range. The number of isolates with MICs above the tentative highest WT MIC for the remaining antibiotics was: ciprofloxacin: 7; levofloxacin: 17; moxifloxacin: 8; rifampicin: 11; doxycycline: 82; tigecycline: 4. EUCAST breakpoints are not available for amoxicillin/clavulanic acid. We estimated the ECOFFs and one isolate had a MIC eightfold higher than the E-test ECOFF. Additionally, a clinical isolate generated three colonies growing on the E-test inhibition zone that resulted in MICs fourfold higher than for the parental isolate.

Conclusions

We report, for the first time, elevated MICs against first-line and other antibiotics (including azithromycin, fluoroquinolones and amoxicillin/clavulanic acid commonly used to treat pneumonia patients in Portugal) in Portuguese L. pneumophila strains. Results point towards decreased susceptibility in circulating strains, justifying further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microbial Sensitivity TestsAnti-Bacterial AgentsLegionella pneumophilaAzithromycinLegionnaires' DiseasePortugalHumansSerogroupDrug Resistance, Bacterial

Stichwörter der Autor:innen

Antibiotic resistanceAntimicrobial susceptibilityLegionella pneumophilaLegionnaires' diseasePortugalPublic healthSurveillance

Substanzen

Anti-Bacterial AgentsAzithromycin

Autor:innen und Institutionen

  • Department of Infectious Diseases, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal.
  • ECDC Fellowship Programme, Public Health Microbiology Path (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Water Microbiology Laboratory, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal.
  • National Reference Laboratory for Legionella, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal. paulo.goncalves@insa.min-saude.pt.

Förderung

  • Instituto Nacional de Saúde Dr. Ricardo Jorge

Zitieren

APA

Minetti, C., Barton, R., Farley, C., Spiller, O. B., Rodrigues, R., & Gonçalves, P. (2024). Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal. European Journal of Clinical Microbiology & Infectious Diseases, 43(7), 1297-1308. https://doi.org/10.1007/s10096-024-04789-9

Vancouver

Minetti C, Barton R, Farley C, Spiller OB, Rodrigues R, Gonçalves P. Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal. European Journal of Clinical Microbiology & Infectious Diseases. 2024;43(7):1297-1308. doi:10.1007/s10096-024-04789-9

BibTeX
@article{Minetti2024,
  author = {Minetti, Corrado and Barton, Rachael and Farley, Caitlin and Spiller, Owen Brad and Rodrigues, Raquel and Gonçalves, Paulo},
  title = {Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  volume = {43},
  number = {7},
  pages = {1297--1308},
  doi = {10.1007/s10096-024-04789-9}
}
Kostenlos starten →